Mendoza-de la Vara HE

Language: Spanish
References: 21
Page: 50-55
PDF size: 57.55 Kb.

ABSTRACT

Nowadays, it is frequent to give attention to patients suffering from coronary artery disease in the operating rooms programmed for non- cardiac surgery. This is because the improvement of the percutaneous coronary intervention technique and the development of intracoronary stent. Through these two techniques it is achieved a good myocardial revascularization without cardiac surgery, increasing life expectation and its quality. However, the healing response from the human organism, the technique of placing and the type of stent, the used co adjuvant therapy, and the time gone from the implant at the surgery day, are all determinant factors in order to decrease or increase events such as thrombosis, restenosis and bleeding, which must be solved by the anesthesiologist. So it is important for the anesthesiologist to know the patient entirely and to be acquainted with the used interventionist procedure. Whether to postpone the surgery or not depends on the security conditions of the patient to be subjected to the surgery, and if it is elective or urgent. The anesthetic technique to be employed after the patient has been evaluated is the anesthesiologist’s election.

REFERENCES

1. Fleisher LA. Strategies to reduce cardiac risk in noncardiac surgery, where are we in 2005? Anesthesiology 2005;v105,5:801-802.

2. Yves DJ, Marino L. Noncardiac surgery in patients with coronary artery stent: what should the anesthesiologist know? Can J Anaesth 2005;52,4:356-361.

3. Newby DE. Prevention of cardiac complications of non-cardiac surgery: stenosis and thrombosis. Br J Anaesth 2004;ed II:328-332.

4. Grossman’s. Cardiac catheterization, angiography, and intervention. Donald S. BAIM. Stents generalitis. Lippincott Williams and Wilkins. Seventh Edition. 2006.

5. Eagle AK, Gibbond RJ, Antman ME, et al. ACC/AHA guideline for perioperative cardiovascular evaluation for noncardiac surgery-executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). JACC Vol. 39, No. 3 2002;6:542-53.

6. Wilson HS, Panayotis F, Orford LJ, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. JACC Vol 42, No. 2, 2003:234-240.

7. Waksman R. Mysteries behind stent struts cathet cardiovasc interv. 2005;65:254-256.

8. Morton JH. Manual de cateterismo cardíaco intervencionista. En: Morton JH, ed. Hand book. 2ª ed. Ed. Científica Interamericana 2005.

9. Warren CJ, Tcheng EJ, Blankenship CJ, O’shea CJ, et al. Temporal spectrum of ischemic complications with percutaneous coronary intervention: the esprit experience. J Invasive Cardiology 2005:1-14.

10. Landerberg G. The pathophysiology of perioperative myocardial infarction: facts and perspectives. J Cardiothoracic Vasc Anaesth 2003:90-100.

11. Gomez JA, Requiera, Fernández NE y cols. Tratamiento de la reestenosis intrastent. Situación actual y perspectivas futuras. Rev Esp Cardiol 1999;52:130-138.

12. Vicenzi MN, Meislitzer T, Heitzinger B, et al. Coronary artery stenting and non-cardiac surgery- a prospective outcome study. Br J Anaesth 2006;96:686-693.

13. Spahn DR, Howell SJ, Delabays A, et al. Coronary stent and perioperative antiplatelet regimen dilemma of bleeding and stent thrombosis. Br J Anesth 2006:675-677.

14. Frishman HW, Sonnenblick HE. Cardiovascular pharmacotherapeutics. (Antiplatelet drug). Second edition. McGraw-Hill, 2004;13:2004-263.

15. Bradley GP, Somers KV. Drugs information handbook for cardiology. Editorial: Lexi Comp Inc. 2001.

16. Wartier CD, Kam CP, Egan KM. Platelet glycoprotein IIb/IIIa antagonists: Pharmacology and clinical developments. Anesthesiology 2002;96,5:1237-1249.

17. Bombeli T, Spahn DR. Updates in perioperative coagulation: physiology and management of thromboembolism and haemorrhage. Br J Anesth 2004;93:275-287.

18. Newby DE, Nimmo AF. Prevention of cardiac complications of non-cardiac surgery: stenosis and thrombosis. Br J Anaesth 2004;92,5:628-632.

19. Garcia EA, Casey M, Szitefman C y cols. Recomendaciones para el uso de los antitrombóticos en la cardiología intervencionista. Rev Argent Cardiol 2003;71,4:282-284.

20. Broad L, Lee T, Conroy M, et al. Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery. Br J Anaesth 2006;98,1:19-22.

21. Becq KMC. La «prise en charge» de un paciente bajo anticoagulantes o antiagregantes plaquetarios antes de una resección transuretral de próstata. Rev Med Univ 2006;2,2:1-3 ó 14-18.